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THE trace element selenium has recently been recognised as an essential constituent
of the enzyme glutathione peroxidase (GSHPx, EC 1.11.1.9) which is thought to
have a major function in the removal of hydrogen peroxide and other organic
hydroperoxides generated during oxidative metabolism.' Both selenium and vitamin
E appear to protect against a myopathic condition seen in young animals put to
pasture in spring after being fed indoors during the winter; this condition has been
observed in England, Scotland and Northern Ireland.2 Keshan disease is a fatal
cardiomyopathy seen in children who live in a region in China where selenium levels
are low in staple foods.3 There have been few reports of selenium deficiency during
long-term total parenteral nutrition.4 5Currently available intravenous nutritional
solutions contain negligible amounts of selenium.5
CASE REPORT
A 39-year-old male with long standing ankylosing spondylitis underwent
manipulative spinal osteotomy to correct spinal deformity. Four days later he
became profoundly shocked, with respiratory and renal failure. Initial laparotomy
revealed a large perforated gastric ulcer. A long complicated illness ensued, with
prolonged respiratory failure necessitating artificial ventilation via a tracheostomy,
dopamine infusion and haemodialysis. A further laparotomy was performed to
drain a subphrenic abscess and a gangrenous gallbladder was removed.
Frequent bouts of septicaemia were treated with a multitude of antibiotics.
Fifteen weeks after the start of his illness, blood cultures were positive for Candida
albicans. A course of anti-fungal drugs was instituted (miconazole and
5-fluorocytosine, with the addition of amikacin).
Two weeks later, a third laparotomy was performed because of persistent
vomiting. There was jejunal obstruction due to adhesions which were divided, and a
feeding duodenostomy was fashioned. During the operation the stump of the cystic
duct was opened, and culture of the bile which escaped grew Candida albicans.
A few days later he suffered an asystolic cardiac arrest from which he was
resuscitated. His condition remained critical, requiring continuous dopamine
infusion, and there were persistent clinical signs of septicaemia. There was a
protracted metabolic acidosis and marked muscle hypotonia. He had now been
maintained on conventional parenteral nutrition supplemented with vitamins
(including tocopherol), trace elements and thrice weekly fat emulsion infusion, for
19 weeks. Serum Fe, Zn, Mg, Cu, B12, foliate, vitamin E and ferritin were all within
normal limits. Amphoteracin B was added to his anti-microbial therapy, and a
preparation of selenium yeast as sold to vegans (200 ug/day) administered via the
duodenal tube. Four days later his condition was so improved that he wished to sit
out of bed. After two weeks, a preparation of selenomethionine became available
130and was administered intravenously (100 ug/day) for 17 days until it was possible to
discontinue all intravenous lines. The patient was discharged to spend Christmas at
home after a record 178 days in the Intensive Care Unit.
DISCUSSION
The normal dietary intake of selenium in man is about 60 ug daily, and there is a
wide range.6 Incapacitating muscular pain in one patient receiving long-term
parenteral nutrition disappeared after selenomethione was added to the intravenous
solution.5 Table I shows the plasma levels of selenium and the red blood cell
concentration of GSHPx during and after therapy, and the currently accepted
normal values. Unfortunately, blood taken prior to the start of therapy was
unsatisfactory for analysis of plasma selenium. Erythrocyte GSHPx level before
treatment was approximately halfthe lower limit ofnormal, but our patient had had
a recent blood transfusion, and it is known that this can confuse the usefulness of
erythrocyte GSHPx activity as an indicator of selenium status by trensfer of the
enzyme via the donor blood.
TABLE 1
Plasma selenium and erythrocyte GSHPx levels before, during, and after therapy.
The last column indicates the normal range.
After After
2 weeks 17 days Four weeks
Time Before enteral parenteral after Normal
ofsample treatment (200ug/day) (lOOug/day) discharge range
Plasma Se
ug/l 39 52 87 80-120
Erythrocyte
GSHPx
iu/g Hb 26 17 23 45 30-60
The efficiency of absorption of selenium from the gut, the bio-availability of oral
preparations, and the effect of sepsis on requirements are all unknown. The amount
of selenium required for supplementation is as yet empirical. The plasma level of
selenium 10 days after cessation of therapy was still below the lower limit of
accepted normal in our patient, but since the total body content of the element is
about 6000 ugs in normal man, gross cellular deficiency may have led to
considerable shift of the element from plasma to cell.
Selenium is an essential trace element for normal cellular function, and GSHPx
protects lipid membranes from oxidative damage and with tocopherol (vitamin E),
helps remove free radicles, superoxide and singlet oxygen.
Animal studies7 indicate that neutrophils from selenium and vitamin E deficient
steers were unable to kill ingested Candida albicans cells and there is evidence to
suggest that there is a decreased immunoglobulin response in vitamin E and
selenium deficient animals.8 Although our patient had normal vitamin E levels
131following intravenous vitamin supplementation, selenium deficiency may have led
to immunosuppression in spite of prolonged antibiotic therapy, and may also have
been the reason for the severe and persistent metabolic acidosis.
The possibility of selenium deficiency should be considered in any patient
receiving total parenteral nutrition for more than four weeks.5
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